Soligenix to Present at Upcoming Conferences [Yahoo! Finance]
Soligenix, Inc. (SNGX)
NASDAQ:AMEX Investor Relations:
soligenix.com/investors
Company Research
Source: Yahoo! Finance
on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Company will deliver a corporate presentation at the upcoming conferences below. Aegis Virtual Conference, held virtually May 7 through 9, 2024 , with opportunities for presentations and networking. The conference will bring together a highly selective group of companies and key business partners, as well as Aegis's extensive network of retail brokers, clients, institutional funds, and money managers who collectively hold access to over $100 billion in capital. BioNJ's 14th Annual BioPartnering Conference, held May 13 through 17, 2024 , featuring in-person and virtual presentations, one-on-one meetings, plenary sessions, and exhibits. For more information, please refer to the conference website at https://bionj.org/bionj-biopartnering-conference/ A.G.P./Alliance Global Partners Healthcare Company Showcase, held virtually on May 21, 2024 , will consist
Show less
Read more
Impact Snapshot
Event Time:
SNGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNGX alerts
High impacting Soligenix, Inc. news events
Weekly update
A roundup of the hottest topics
SNGX
News
- Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice [Yahoo! Finance]Yahoo! Finance
- Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical PracticePR Newswire
- Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial ResultsPR Newswire
- Soligenix to Present at Upcoming ConferencesPR Newswire
SNGX
Sec Filings
- 5/17/24 - Form 8-K
- 5/17/24 - Form DEFA14A
- 5/15/24 - Form DEFA14A
- SNGX's page on the SEC website